- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
The partner for this project was selected by the Corporation among the leading Russian business schools. It is the Moscow Management School SKOLKOVO, which will raise the 1 billion rubles adding to the fund's chartered capital. The total fund amount will reach 2 billion rubles. The Managing Company of the fund will be Troyka Dialog.
From the opinion of the managing director, member of RUSNANO Board of Directors Dionis Gordin, the joint project of RUSNANO and SKOLKOVO is a striking example of melding the Corporation's educational and investment objectives: the trust activity will be directed towards discovery of the commercial potential of the Russian nanotechnologies, providing the trust investors with high return of their investments as well as improving the quality of training in the sphere of innovative management and building of the efficient practice within the business school framework.
- One of the problems with venture business today is that there is a gap between a business idea and its implementation in the investment project, says Dionis Gordin. - In average, less than 10% of the projects submitted to the venture trusts pass through the primary consideration stage. It happens due to low quality of the business plans, calculations, marketing researches, scientific and technical substantiation etc. The venture trust will involve the students and tutors of SKOLKOVO into business planning and pre-investment preparation of the most interesting projects submitted into the Fund.
- We value the advantages and perspectives opening for our students thanks to cooperation with the Russian Corporation of Nanotechnologies, emphasized Andrey Volkov, Head of Moscow Management School SKOLKOVO. - Program SKOLKOVO MBA which will be launched in 2009 implies the development of own business projects by students. The best projects will obtain venture financing. The criterion of the project selection is their innovative component. We are sure that our cooperation with RUSNANO will motivate them for creating truly advanced technologies beneficial not only for their authors but for our country as well.
About Russian Corporation of Nanotechnologies
Russian Corporation of Nanotechnologies (RUSNANO) was established in 2007 by the Federal law № 139-FZ to enable Government policy in the field of Nanotechnology.
To accomplish this task, the Corporation co-invests in nanoindustry projects with high commercial potential or social benefit. Early stage investment from the Corporation lowers the risk of its investment partners from the private sector.
The Corporation participates in building nanotechnology infrastructure, which includes the nanotechnology centers of excellence, business incubators and early stage investment funds. The Corporation provides scientific and educational programs that are required for its investment projects to succeed, and also supports the popularization of nanoscience and nanotechnology. The Corporation selects projects for investment on the basis of longer-term foresights/predictions created by the leading Russian and world experts.
To assist the Russian nanoindustry advance to the global market and strengthening of its international links the Corporation develops partnerships with the leading nanotechnology centers in the world and organizes the annual Nanotechnology International Forum in Russia.
For more information, please click here
Russian Corporation of Nanotechnologies
Nametkina Street, 12A, Moscow, Russia 117420
Phone: +7 495 542 4444
Fax: +7 495 542 4434
Copyright © Russian Corporation of NanotechnologiesIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Nanotechnology identifies brain tumor types through MRI 'virtual biopsy' in animal studies: If results are confirmed in humans, tumor cells could someday be diagnosed by MRI imaging and treated with tumor-specific IV injections; new NIH grant will fund future study May 27th, 2015
BESSTECH Announces $250K Investment from Eastern New York Angels : Funding will accelerate commercialization of BESSTECH’s innovative lithium-ion battery electrode technology and enable hiring of key personnel May 13th, 2015
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
One step closer to a single-molecule device: Columbia Engineering researchers first to create a single-molecule diode -- the ultimate in miniaturization for electronic devices -- with potential for real-world applications May 25th, 2015